McKesson (MCK) Q4 2025 (USD): Adj. EPS 11.69 (exp. 11.56), Revenue 96.3bln (exp. 101.35bln)

McKesson's Q4 results show an adjusted EPS beat, coming in above expectations, which bodes well for investor sentiment. However, the significant miss on revenue raises questions about demand and could temper optimism about future growth. Traders should watch for stock volatility as the market digests these mixed signals and how it may impact healthcare sector valuations.